A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP) (2016)

First Author: Phillips P

Attributed to: Tuberculosis Treatment Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12916-016-0597-3

PubMed Identifier: 27004726

Publication URI: http://europepmc.org/abstract/MED/27004726

Type: Journal Article/Review

Parent Publication: BMC Medicine

Issue: 1

ISSN: 1741-7015